BioCircuit Technologies
Atlanta, US · Founded 2016 · Georgia corporation · 1 known investors
Founders & leadership
JN
James NahirnyDirector
TO
Thomas O'BrienExecutive Officer, Director
MJ
Michelle JarrardExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$9MraisedOct 2022 · 33 investors · BiotechnologyRule 506(b)
▶$9MraisedOct 2022 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michelle JarrardExecutive Officer, Director
- James NahirnyDirector
- Michael MastersDirector
- Thomas O'BrienDirector
- Offering amount
- $9M
- Amount sold
- $9M
- First sale
- Sep 2022
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 04, 06b
▶$3.1MraisedApr 2021 · 13 investors · BiotechnologyRule 506(b)
▶$3.1MraisedApr 2021 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James NahirnyDirector
- Michael MastersDirector
- Thomas O'BrienDirector
- Michelle JarrardExecutive Officer, Director
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- First sale
- Apr 2021
- Incorporated
- Corporation, Georgia, 2016
- Federal exemptions
- 04, 06b
▶$1.5MraisedApr 2021 · 7 investors · BiotechnologyRule 506(b)
▶$1.5MraisedApr 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michelle JarrardExecutive Officer, Director
- James NahirnyDirector
- Thomas O'BrienExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- May 2019
- Incorporated
- Corporation, Georgia, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $1.9M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.